Palo Alto Investors

Palo Alto Investors as of Sept. 30, 2017

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 40 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abiomed 13.7 $326M 1.9M 168.60
Clovis Oncology 11.6 $274M 3.3M 82.40
BioMarin Pharmaceutical (BMRN) 9.6 $227M 2.4M 93.07
United Therapeutics Corporation (UTHR) 8.7 $207M 1.8M 117.19
Insmed (INSM) 8.1 $193M 6.2M 31.21
Alexion Pharmaceuticals 6.4 $152M 1.1M 140.29
Epizyme 5.1 $122M 6.4M 19.05
Amicus Therapeutics (FOLD) 4.7 $112M 7.4M 15.08
Vanda Pharmaceuticals (VNDA) 3.1 $74M 4.2M 17.90
Prothena (PRTA) 3.0 $71M 1.1M 64.77
Wright Medical Group Nv 2.9 $69M 2.7M 25.87
AMAG Pharmaceuticals 2.7 $64M 3.4M 18.45
ACADIA Pharmaceuticals (ACAD) 2.6 $62M 1.6M 37.67
Sage Therapeutics (SAGE) 2.1 $49M 787k 62.30
STAAR Surgical Company (STAA) 1.8 $44M 3.5M 12.45
Celgene Corporation 1.8 $43M 295k 145.82
Immunomedics 1.8 $42M 3.0M 13.98
Align Technology (ALGN) 1.8 $42M 223k 186.27
Karyopharm Therapeutics (KPTI) 1.6 $38M 3.5M 10.98
Momenta Pharmaceuticals 1.4 $33M 1.8M 18.50
Aimmune Therapeutics 1.4 $32M 1.3M 24.79
EXACT Sciences Corporation (EXAS) 0.9 $20M 433k 47.12
Shire 0.8 $20M 130k 153.14
Gilead Sciences (GILD) 0.6 $14M 176k 81.02
Bioverativ Inc Com equity 0.5 $12M 211k 57.07
Rigel Pharmaceuticals (RIGL) 0.4 $9.8M 3.9M 2.54
Acelrx Pharmaceuticals 0.2 $4.8M 1.0M 4.60
Alimera Sciences 0.2 $4.1M 3.0M 1.35
Dicerna Pharmaceuticals 0.1 $2.9M 501k 5.75
Sunesis Pharmaceuticals Inc Ne 0.1 $2.3M 1.2M 1.94
Cytokinetics (CYTK) 0.1 $1.8M 124k 14.50
Idera Pharmaceuticals 0.1 $1.4M 616k 2.23
Cempra 0.1 $1.1M 340k 3.25
Trevena 0.0 $870k 341k 2.55
Zogenix 0.0 $1.0M 30k 35.05
Alder Biopharmaceuticals 0.0 $789k 64k 12.25
Histogenics Corp Cmn 0.0 $600k 303k 1.98
Sophiris Bio 0.0 $531k 247k 2.15
Alcobra 0.0 $276k 273k 1.01
Soleno Therapeutics 0.0 $220k 85k 2.60